Agenus (AGEN) Revenue Growth (5y) (2015 - 2026)
Agenus (AGEN) Revenue Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,831.58 Bn | 66,831.30 Bn | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - |
| 3 | Akari Therapeutics | 976.78 Bn | 976.78 Bn | - |
| 4 | BeOne Medicines | 471.48 Bn | 466.69 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.78 Bn | 114.53 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.54 Bn | 34.53 Bn | 959.66 Mn |
| 10 | Agenus | 234.48 Mn | 199.48 Mn | 33.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.55% |
| Dec 31, 2025 | 1.81% |
| Sep 30, 2025 | 15.31% |
| Jun 30, 2025 | -0.95% |
| Mar 31, 2025 | 9.73% |
| Dec 31, 2024 | -4.90% |
| Sep 30, 2024 | 4.72% |
| Jun 30, 2024 | 8.39% |
| Mar 31, 2024 | -18.91% |
| Dec 31, 2023 | 67.00% |
| Sep 30, 2023 | 13.69% |
| Jun 30, 2023 | 9.74% |
| Mar 31, 2023 | 69.52% |
| Dec 31, 2022 | -48.85% |
| Sep 30, 2022 | 46.64% |
| Jun 30, 2022 | 37.82% |
| Mar 31, 2022 | -0.76% |
| Dec 31, 2021 | 29.44% |
| Sep 30, 2021 | 124.40% |
| Jun 30, 2021 | 10.23% |